Autologous Tumor Vaccination

Abstract

The concept was to implant, subcutaneously, breast cancer cells in syngeneic rats, inject immune system stimulators entrapped in a sustained release gel into the tumor and observe a short term and a long term immune response to the tumor. Tumors appeared about 8 days after injecting 1,000,000 cells. As soon as we injected 100 ug of N-formyl-Met-Leu-Phe and 0.1 ug of IL-12 in 0.3 ml of gel, an anti-tumor immune response ensued. Tumor growth halted for about 4 days and then resumed at the rate of untreated control cells. If the tumor was re-injected a second and then a third time, tumor growth halted and resumed. However, 3 consecutive injections was not sufficient to induce a long term response. These results were reproducible and encouraging, considering it was a first attempt. Either stimulant alone or both in combination gave the same results. If continued, we would have to develop a gel formulation that would release the stimulants more slowly than the half- time of about 1 day with the present gel.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Jul 01, 2002
Accession Number
ADA407668

Entities

People

  • Michael J. Leibowitz
  • Stanley Stein

Tags

DTIC Thesaurus Topics

  • Blood
  • Breast Cancer
  • Cell Physiological Processes
  • Cells
  • Chemical Synthesis
  • Chemistry
  • Lymphatic System
  • Lymphocytes
  • Medical Personnel
  • Proteins
  • Tissues
  • Vaccines

Fields of Study

  • Biology

Readers

  • Analytical Chemistry
  • Immunology
  • Oncology

Technology Areas

  • Biotechnology
  • Biotechnology - Cancer Biotech